EUVIMEDOpdag EUVIMED
Crossref

Mechanistic Insights into As III S-Adenosylmethionine Methyltransferase with Selenoimidazolium-Based Methylating Agents

Rudra Shankar Pati iD, Rakesh Kumar Rai, Amirul Islam, Gouriprasanna Roy iD

Inorganic Chemistry · 2026

DOI: 10.1021/acs.inorgchem.5c04653 ↗

At a glance

Journal article in Inorganic Chemistry, 2026. Written by Rudra Shankar Pati and 3 co-authors. Institution: Department of Chemistry, Indian Institute of Technology Tirupati, Tirupati, AP 517619, India. Major MEDLINE topics: Methyltransferases, Imidazoles, Organoselenium Compounds, Arsenites. 116 references. Funded by: Science and Engineering Research Board, Indian Institute of Technology Tirupati, Ministry of Education, India.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Arsenite S-adenosylmethionine methyltransferase (ArsM), together with S-adenosylmethionine (SAM) cofactor, catalyzes the stepwise methylation of arsenite (iAsIII) to carcinogenic monomethylated (MMAs) and less toxic di- or trimethylated arsenicals (DMAs or TMAs). The molecular origins of the widely varying methylation efficiencies of ArsMs across organisms remain unclear. Here, we report a series of selenoimidazolium-based methylating agents that display distinct reactivity profiles and varying efficiencies in converting iAsIII to DMAsV. The selenium analogues significantly outperform both their sulfur counterparts and SAM, the universal biological methyl donor. Methylation efficiency-governed by Se-CH3 bond activation, transition-state stabilization, and reduction of pentavalent MMAsV intermediate-increases in the order 2 < 5 < 6 ≪ 7 ≪ 9. Notably, the macrocyclic agent 9 displays exceptional reactivity, achieving 98% conversion and rate enhancements of up to ∼90-fold relative to SAM, driven by a network of cooperative noncovalent interactions that facilitate an SN2 pathway. Consistent with this mechanism, steric enlargement of the alkyl group suppresses reactivity. Furthermore, in situ generated selone byproducts facilitate reduction of pentavalent MMAsV intermediate, thereby accelerating DMAs formation in the arsenic methylation cycle. Collectively, these findings establish selenoimidazolium methyl donors as highly effective biomimetic methylating agents and provide design principles for advanced arsenic detoxification strategies.

Subjects

MeSH terms (MEDLINE)

MethyltransferasesImidazolesOrganoselenium CompoundsArsenitesMethylationMolecular StructureS-Adenosylmethionine

Substances

MethyltransferasesImidazolesOrganoselenium CompoundsS-AdenosylmethionineArsenites

Authors and institutions

  • Department of Chemistry, Indian Institute of Technology Tirupati, Tirupati, AP 517619, India.

ORCID profiles: Rudra Shankar Pati, Gouriprasanna Roy

Funding

  • Science and Engineering Research Board
  • Indian Institute of Technology Tirupati
  • Ministry of Education, India

Cite

APA

Pati, R. S., Rai, R. K., Islam, A., & Roy, G. (2026). Mechanistic Insights into As III S-Adenosylmethionine Methyltransferase with Selenoimidazolium-Based Methylating Agents. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.5c04653

Vancouver

Pati RS, Rai RK, Islam A, Roy G. Mechanistic Insights into As III S-Adenosylmethionine Methyltransferase with Selenoimidazolium-Based Methylating Agents. Inorganic Chemistry. 2026. doi:10.1021/acs.inorgchem.5c04653

BibTeX
@article{Pati2026,
  author = {Pati, Rudra Shankar and Rai, Rakesh Kumar and Islam, Amirul and Roy, Gouriprasanna},
  title = {Mechanistic Insights into As III S-Adenosylmethionine Methyltransferase with Selenoimidazolium-Based Methylating Agents},
  journal = {Inorganic Chemistry},
  year = {2026},
  doi = {10.1021/acs.inorgchem.5c04653}
}
Start for free →